Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00615121 · ClinicalTrials.gov registry record
Genetics of Peripheral Artery Genomics
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 122
- Enrollment target
NCT00615121 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 122 participants.
The verdict
NCT00615121 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 122 participants
- Enrollment target
Study Summary
Peripheral artery disease is a disease that contributes to significant morbidity and mortality of millions of Americans yearly. Very little is known about the pathophysiology of atherosclerosis in peripheral artery disease. We plan to collect peripheral arteries and muscle tissue from patients undergoing amputation for end stage peripheral arterial occlusive disease. By extracting the RNA from these arteries and tissues and comparing them with RNA expression from normal arteries, we hope to have a better understanding of the pathophysiology of atherosclerosis in this setting. We aim to prove the hypothesis that a novel gene expression pattern can be discovered by the successful extraction of RNA from plaques from human peripheral arteries.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 122 participants |
| Start Date | 2004-06 |
| Est. Completion | 2016-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00615121
The ClinicalTrials.gov registry entry for NCT00615121 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 122 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00615121 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00615121 about?
NCT00615121 is a clinical study titled "Genetics of Peripheral Artery Genomics". Peripheral artery disease is a disease that contributes to significant morbidity and mortality of millions of Americans yearly. Very little is known about the pathophysiology of atherosclerosis in peripheral artery disease. We plan to collect peripheral arteries and muscle tissue from patients under...
What is the current status of trial NCT00615121?
This trial is currently completed. The enrollment target is 122 participants. The study started on 2004-06. Estimated completion is 2016-01.
Who is sponsoring clinical trial NCT00615121?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.